Arterial Tortuosity Syndrome: An Ascorbate Compartmentalization Disorder?

• Published in: Antioxidants & redox signaling Vol. 34; no. 11; p. 875
• Main Authors: Boel, Annekatrien, Veszelyi, Krisztina, Németh, Csilla E, Beyens, Aude, Willaert, Andy, Coucke, Paul, Callewaert, Bert, Margittai, Éva
• Format: Journal Article
• Language: English
• Published: United States 10.04.2021
• Subjects: ascorbate; compartmentalization; GLUT10; arterial tortuosity syndrome
• ISSN: 1557-7716
• DOI: 10.1089/ars.2019.7843

Cardiovascular disorders are the most important cause of morbidity and mortality in the Western world. Monogenic developmental disorders of the heart and vessels are highly valuable to study the physiological and pathological processes in cardiovascular system homeostasis. The arterial tortuosity syndrome (ATS) is a rare, autosomal recessive connective tissue disorder showing lengthening, tortuosity, and stenosis of the large arteries, with a propensity for aneurysm formation. In histopathology, it associates with fragmentation and disorganization of elastic fibers in several tissues, including the arterial wall. ATS is caused by pathogenic variants in encoding the facilitative glucose transporter (GLUT)10. Although several hypotheses have been forwarded, the molecular mechanisms linking disrupted GLUT10 activity with arterial malformations are largely unknown. The vascular and systemic manifestations and natural history of ATS patients have been largely delineated. GLUT10 was identified as an intracellular transporter of dehydroascorbic acid, which contributes to collagen and elastin cross-linking in the endoplasmic reticulum, redox homeostasis in the mitochondria, and global and gene-specific methylation/hydroxymethylation affecting epigenetic regulation in the nucleus. We revise here the current knowledge on ATS and the role of GLUT10 within the compartmentalization of ascorbate in physiological and diseased states. Centralization of clinical, treatment, and outcome data will enable better management for ATS patients. Establishment of representative animal disease models could facilitate the study of pathomechanisms underlying ATS. This might be relevant for other forms of vascular dysplasia, such as isolated aneurysm formation, hypertensive vasculopathy, and neovascularization. . 34, 875-889.